In this episode, we dive into the Gout Therapeutics Market, set to expand from $3.27 billion in 2025 to $5.49 billion by 2033, with a 6.70% CAGR. With lifestyle-related diseases like obesity, diabetes, and hypertension on the rise, along with breakthroughs in biologic and uric acid-lowering therapies, the market is evolving rapidly. Join us as we explore the key trends shaping the future of gout treatment!